Name (Synonyms) | Correlation | |
---|---|---|
drug1758 | Pandemic control measures Wiki | 1.00 |
drug386 | Blood sampling Wiki | 0.58 |
There is one clinical trial.
This is a prospective, epidemiological, cohort study to assess the feasibility of screening healthy asymptomatic workers for the presence of severe acute respiratory syndrome SARS-CoV-2 by pharyngeal swaps and serology at baseline, day 21 and day 40.
Description: Evaluation of immune responses to components of SARS-CoV-2 as well as evaluation of Swab for the presence of SARS-CoV-2 by PCR. Determination of the difference between the study groups in anti-SARS-CoV 2 seropositivity status. Analysis of trends in CD4/CD8 concentrations over time and correlation with immunoglobulin G (IgG) Levels and new assay evaluation.
Measure: Immune responses to components of SARS-Cov-2 Time: up to visit 3 (day 40)Description: Evaluation of Swab for the presence of SARS-CoV-2 by PCR and determination of the difference between the study groups in anti-SARS-CoV 2 seropositivity status.
Measure: Swabs for the presence of SARSCoV-2 Time: up to visit 3 (day 40)Description: Evaluation of immune responses to components of SARS-CoV-2 as well as evaluation of Swab for the presence of SARS-CoV-2 by PCR. Determination of the difference between the study groups in anti-SARS-CoV 2 seropositivity status and analysis of trends in CD4/CD8 concentrations over time and correlation with IgG Levels as well as new assay evaluation.
Measure: Difference between the study groups in anti-SARS-CoV 2 seropositivity status Time: up to visit 3 (day 40)